Press Release from Dr. Anne Hardy, Public Relations und Kommunikation, Goethe-Universität Frankfurt am Main
Published by Technology Networks Group – a global community of researchers and scientific professionals from the life science, drug discovery and analytical arenas,
on April 05, 2016
More and more children are affected by type 1 diabetes in Europe and in the USA. A group of European researchers has received a grant of 5 million euros from the E.U for developing an alternative to lifelong insulin therapy.
The aim of the 4 years’ project is to grow in the laboratory three-dimensional cellular structures of insulin-producing cells and to set up a mass production process. The group from the Goethe University of Frankfurt is dedicated to controlling the growth of the organoids through light-sheet fluorescence microscope. Two groups of researchers from Cambridge are specialised in isolating insulin-producing cells from donors, while a group of clinicians from Milan has developed methods for organoids’ transplantation. The project will also ensure to develop protocols to respect the good practices manufacturing standards.
You can read the article here: www.technologynetworks.com/cell-culture
About Technology Networks Group:
Technology Networks Group is a publisher, which consists of a global community of over 250,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.
Technology Networks Group website: www.technologynetworks.com